BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 27573580)

  • 1. Clostridium difficile colitis: pathogenesis and host defence.
    Abt MC; McKenney PT; Pamer EG
    Nat Rev Microbiol; 2016 Oct; 14(10):609-20. PubMed ID: 27573580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth.
    Weingarden AR; Dosa PI; DeWinter E; Steer CJ; Shaughnessy MK; Johnson JR; Khoruts A; Sadowsky MJ
    PLoS One; 2016; 11(1):e0147210. PubMed ID: 26789728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenicity Locus, Core Genome, and Accessory Gene Contributions to
    Lewis BB; Carter RA; Ling L; Leiner I; Taur Y; Kamboj M; Dubberke ER; Xavier J; Pamer EG
    mBio; 2017 Aug; 8(4):. PubMed ID: 28790208
    [No Abstract]   [Full Text] [Related]  

  • 4. The microbiota and immune response during Clostridium difficile infection.
    Buonomo EL; Petri WA
    Anaerobe; 2016 Oct; 41():79-84. PubMed ID: 27212111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile spore germination: an update.
    Burns DA; Heap JT; Minton NP
    Res Microbiol; 2010 Nov; 161(9):730-4. PubMed ID: 20863888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.
    Vincent C; Miller MA; Edens TJ; Mehrotra S; Dewar K; Manges AR
    Microbiome; 2016 Mar; 4():12. PubMed ID: 26975510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal microbiota transplantation: a new standard treatment option for Clostridium difficile infection.
    Borody TJ; Brandt LJ; Paramsothy S; Agrawal G
    Expert Rev Anti Infect Ther; 2013 May; 11(5):447-9. PubMed ID: 23627849
    [No Abstract]   [Full Text] [Related]  

  • 8. Dynamics and establishment of Clostridium difficile infection in the murine gastrointestinal tract.
    Koenigsknecht MJ; Theriot CM; Bergin IL; Schumacher CA; Schloss PD; Young VB
    Infect Immun; 2015 Mar; 83(3):934-41. PubMed ID: 25534943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of bacterial metabolism and physiology in the pathogenesis of Clostridium difficile disease.
    Bongaerts GP; Lyerly DM
    Microb Pathog; 1997 Apr; 22(4):253-6. PubMed ID: 9140922
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory maintenance of Clostridium difficile.
    Sorg JA; Dineen SS
    Curr Protoc Microbiol; 2009 Feb; Chapter 9():Unit9A.1. PubMed ID: 19235151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New trends in Clostridium difficile virulence and pathogenesis.
    Denève C; Janoir C; Poilane I; Fantinato C; Collignon A
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S24-8. PubMed ID: 19303565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile.
    Britton RA; Young VB
    Gastroenterology; 2014 May; 146(6):1547-53. PubMed ID: 24503131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular basis of Clostridium difficile disease and host response.
    El Feghaly RE; Bangar H; Haslam DB
    Curr Opin Gastroenterol; 2015 Jan; 31(1):24-9. PubMed ID: 25394235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses induced by Clostridium difficile.
    Péchiné S; Collignon A
    Anaerobe; 2016 Oct; 41():68-78. PubMed ID: 27108093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germinant Synergy Facilitates Clostridium difficile Spore Germination under Physiological Conditions.
    Kochan TJ; Shoshiev MS; Hastie JL; Somers MJ; Plotnick YM; Gutierrez-Munoz DF; Foss ED; Schubert AM; Smith AD; Zimmerman SK; Carlson PE; Hanna PC
    mSphere; 2018 Sep; 3(5):. PubMed ID: 30185513
    [No Abstract]   [Full Text] [Related]  

  • 16. Intestinal calcium and bile salts facilitate germination of Clostridium difficile spores.
    Kochan TJ; Somers MJ; Kaiser AM; Shoshiev MS; Hagan AK; Hastie JL; Giordano NP; Smith AD; Schubert AM; Carlson PE; Hanna PC
    PLoS Pathog; 2017 Jul; 13(7):e1006443. PubMed ID: 28704538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile virulence factors: Insights into an anaerobic spore-forming pathogen.
    Awad MM; Johanesen PA; Carter GP; Rose E; Lyras D
    Gut Microbes; 2014; 5(5):579-93. PubMed ID: 25483328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium difficile and the disease it causes.
    Norén T
    Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of microbial derived secondary bile acids on colonization resistance against Clostridium difficile in the gastrointestinal tract.
    Winston JA; Theriot CM
    Anaerobe; 2016 Oct; 41():44-50. PubMed ID: 27163871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal microbiota transplantation in the treatment of Clostridium difficile infections.
    Austin M; Mellow M; Tierney WM
    Am J Med; 2014 Jun; 127(6):479-83. PubMed ID: 24582877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.